Last reviewed · How we verify

NCT05146934: IIP

The Relationship Between Hormone Sensitivity and Imaging of Idiopathic Interstitial Pneumonia by Artificial Intelligence

Completed Last updated 7 December 2021
What this trial tests

trial testing high resolution CT in Idiopathic Interstitial Pneumonia in 150 participants. Completed in 30 June 2021.

Timeline
30 December 2019
Primary endpoint
1 June 2021
30 June 2021

Quick facts

Lead sponsorPeking University Third Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date30 December 2019
Primary completion1 June 2021
Estimated completion30 June 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Adults 18 to 90, any sex, with Idiopathic Interstitial Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Application of artificial intelligence deep learning algorithm to analyze the relationship between hormone sensitivity of idiopathic interstitial pneumonia and imaging features of high resolution CT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05146934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing